​

aTyr Pharma (ATYR) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

ATYR Stock Rating

aTyr Pharma stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

ATYR Price Target Upside V Benchmarks

TypeNameUpside
StockaTyr Pharma-
SectorHealthcare Stocks 25.10%
IndustryBiotech Stocks 61.24%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.25$4.25$4.25
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 2544---8
Jan, 2544---8
Dec, 2443---7
Nov, 2445---9
Oct, 2445---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2024H.C. WainwrightBuyBuyhold
Oct 21, 2024Piper SandlerOverweightOverweighthold
Oct 04, 2024Wells FargoOverweightinitialise
Sep 05, 2024JefferiesBuyinitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.77$-1.77$-1.60$-0.94-----
Avg Forecast$-2.17$-1.79$-1.82$-0.93$-0.91$-0.81$-0.60$0.33$1.70
High Forecast$-2.14$-1.77$-1.82$-0.93$-0.90$-0.77$-0.60$0.33$1.70
Low Forecast$-2.21$-1.83$-1.82$-0.93$-0.92$-0.86$-0.60$0.33$1.70
Surprise %-18.43%-1.12%-12.09%1.08%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.46M-$10.39M$353.00K-----
Avg Forecast$8.53M$2.16M$357.14K$421.20K$241.11K$2.85M$37.45M$167.72M$335.76M
High Forecast$8.66M$2.19M$357.14K$421.20K$275.56K$2.85M$37.45M$167.72M$335.76M
Low Forecast$8.46M$2.14M$357.14K$421.20K$229.63K$2.85M$37.45M$167.72M$335.76M
Surprise %22.52%-2808.08%-16.19%-----

Net Income Forecast

$-150M $-100M $-50M $0 $50M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-16.22M$-33.77M$-45.34M$-50.39M-----
Avg Forecast$-116.15M$-96.13M$-97.56M$-50.07M$-48.96M$-43.48M$-32.36M$17.69M$90.90M
High Forecast$-114.86M$-95.07M$-97.56M$-50.07M$-48.42M$-41.12M$-32.36M$17.69M$90.90M
Low Forecast$-118.37M$-97.97M$-97.56M$-50.07M$-49.50M$-46.32M$-32.36M$17.69M$90.90M
Surprise %-86.03%-64.87%-53.53%0.64%-----

ATYR Forecast FAQ

Is aTyr Pharma stock a buy?

aTyr Pharma stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that aTyr Pharma is a favorable investment for most analysts.

What is aTyr Pharma's price target?

aTyr Pharma's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $4.25.

How does aTyr Pharma stock forecast compare to its benchmarks?

aTyr Pharma's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.10%) and underperforming the biotech stocks industry (61.24%).

What is the breakdown of analyst ratings for aTyr Pharma over the past three months?

  • February 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 57.14% Strong Buy, 42.86% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is aTyr Pharma’s EPS forecast?

aTyr Pharma's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.91, marking a -3.19% decrease from the reported $-0.94 in 2023. Estimates for the following years are $-0.81 in 2025, $-0.6 in 2026, $0.33 in 2027, and $1.7 in 2028.

What is aTyr Pharma’s revenue forecast?

aTyr Pharma's average annual revenue forecast for its fiscal year ending in December 2024 is $241.11K, reflecting a -31.70% decrease from the reported $353K in 2023. The forecast for 2025 is $2.85M, followed by $37.45M for 2026, $167.72M for 2027, and $335.76M for 2028.

What is aTyr Pharma’s net income forecast?

aTyr Pharma's net income forecast for the fiscal year ending in December 2024 stands at $-48.96M, representing a -2.84% decrease from the reported $-50.389M in 2023. Projections indicate $-43.481M in 2025, $-32.365M in 2026, $17.69M in 2027, and $90.9M in 2028.